Spitze Pharma Private Limited
About Spitze Pharma Private Limited
Data last updated:
Spitze Pharma Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 02 July 2010 and has been in existence for over 16 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24239MH2010PTC205146. Its GSTIN is 27AAOCS5505K1ZX (Maharashtra).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Atul Laxmidas Lakhani and Kalpa Atul Lakhani.
Its last annual general meeting (AGM) was held on 30 November 2021, and its latest financial statements are for the year ended 31 March 2021. The registered office is at C 101 Jamad Agni Saptshri Park Off L B S Mar Mulund West, Mumbai, Maharashtra, India – 400080.
As per MCA filings, the company has open charges of ₹25 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Spitze Pharma Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressC 101 Jamad Agni Saptshri Park Off L B S Mar Mulund West, Mumbai, Maharashtra, India – 400080
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Spitze Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Spitze Pharma Private Limited
FY 2021 filings availableSpitze Pharma Private Limited reported revenue of ₹4,375 (down 99% YoY) for FY 2020.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 68% over five years, including a 99% fall in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹4,375 | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | |||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | |||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Spitze Pharma Private Limited, buy the company report.
Board of directors of Spitze Pharma Private Limited
Spitze Pharma has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Atul Laxmidas Lakhani | Director | 02 Jul 2010 | 16 Years 3 Months | Current |
| Kalpa Atul Lakhani | Additional Director | 17 Mar 2022 | 4 Years 7 Months | Current |
Auditor
Spitze Pharma Private Limited is audited by ABHYANKAR & COMPANY for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ABHYANKAR & COMPANY | FY 2019 | 100024W |
Shareholding
The shareholding of Spitze Pharma Private Limited is on record for 3 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Spitze Pharma Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 31 Jan 2011 | 10267220 | The Saraswat Co-Operative Bank Limited | ₹25 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Spitze Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Spitze Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Spitze Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAOCS5505K1ZX | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Spitze Pharma Private Limited, buy the company report.
Recent activity
Spitze Pharma Private Limited has 4 board changes on record since 2010: 2 appointments and 2 cessations. The latest: Bharat Jagjivan Bhate ceased to be Director on 17 Mar 2022.
Frequently asked questions
Spitze Pharma is an active private limited company based in Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 02 July 2010 (16+ years old) and is registered under CIN U24239MH2010PTC205146.
Spitze Pharma has 2 current directors:
- Atul Laxmidas Lakhani - Director
- Kalpa Atul Lakhani - Additional Director
The latest financial statements of Spitze Pharma on record with the MCA are for the year ended 31 March 2021. Its last annual general meeting was held on 30 November 2021. Year-wise statements from 2015 are in the company report.
The GSTIN of Spitze Pharma is 27AAOCS5505K1ZX, registered in Maharashtra.
The CIN (Corporate Identification Number) of Spitze Pharma is U24239MH2010PTC205146. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Spitze Pharma was incorporated on 02 July 2010, making it 16+ years old. It is registered with the Registrar of Companies, Mumbai.
Bharat Jagjivan Bhate ceased to be Director on 17 Mar 2022. Kalpa Atul Lakhani was appointed as Additional Director on 17 Mar 2022. Sandeep Jagjeevan Modi ceased to be Director on 17 Mar 2022. Spitze Pharma has 4 board changes on record in total.
The registered office of Spitze Pharma is at C 101 Jamad Agni Saptshri Park Off L B S Mar Mulund West, Mumbai, Maharashtra, India – 400080.
Spitze Pharma operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Spitze Pharma has open charges of ₹25 Lakh and no satisfied charges on record as per latest MCA filings.